1. Home
  2. ELVN vs THR Comparison

ELVN vs THR Comparison

Compare ELVN & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • THR
  • Stock Information
  • Founded
  • ELVN 2016
  • THR 1954
  • Country
  • ELVN United States
  • THR United States
  • Employees
  • ELVN N/A
  • THR N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • THR Industrial Machinery/Components
  • Sector
  • ELVN Health Care
  • THR Energy
  • Exchange
  • ELVN Nasdaq
  • THR Nasdaq
  • Market Cap
  • ELVN 1.1B
  • THR 960.7M
  • IPO Year
  • ELVN 2020
  • THR 2011
  • Fundamental
  • Price
  • ELVN $22.47
  • THR $28.69
  • Analyst Decision
  • ELVN Strong Buy
  • THR Strong Buy
  • Analyst Count
  • ELVN 5
  • THR 1
  • Target Price
  • ELVN $37.80
  • THR $38.00
  • AVG Volume (30 Days)
  • ELVN 204.7K
  • THR 209.4K
  • Earning Date
  • ELVN 11-13-2024
  • THR 01-30-2025
  • Dividend Yield
  • ELVN N/A
  • THR N/A
  • EPS Growth
  • ELVN N/A
  • THR 4.78
  • EPS
  • ELVN N/A
  • THR 1.29
  • Revenue
  • ELVN N/A
  • THR $493,855,000.00
  • Revenue This Year
  • ELVN N/A
  • THR $2.25
  • Revenue Next Year
  • ELVN N/A
  • THR $8.83
  • P/E Ratio
  • ELVN N/A
  • THR $22.26
  • Revenue Growth
  • ELVN N/A
  • THR 3.94
  • 52 Week Low
  • ELVN $10.90
  • THR $23.76
  • 52 Week High
  • ELVN $30.03
  • THR $35.93
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 39.53
  • THR 32.13
  • Support Level
  • ELVN $21.84
  • THR $30.95
  • Resistance Level
  • ELVN $24.42
  • THR $33.25
  • Average True Range (ATR)
  • ELVN 1.59
  • THR 1.03
  • MACD
  • ELVN -0.05
  • THR -0.49
  • Stochastic Oscillator
  • ELVN 18.27
  • THR 4.20

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

About THR Thermon Group Holdings Inc.

Thermon Group Holdings Inc is a United States-based company that provides engineered thermal solutions for process industries. The company's product portfolio comprises electric heat tracing cables, steam tracing components, tubing bundles, and instrument and control products, as well as complementary product lines. It also provides turnkey services and design and engineering services. The company's customers include large engineering, procurement, and construction companies; oil and gas companies; commercial subcontractors; electrical component distributors; and others. The company has a presence, with the United States, Canada, and Europe being its top three markets and contributing the majority of its sales.

Share on Social Networks: